Global  

No major mutation observed in SARS-COV 2, no indication vaccine strategy would be hindered: Study

IndiaTimes Sunday, 18 October 2020
A pan-India study by the Department of Biotechnology suggests that A2a strain of SARS-CoV-2, which is the prominent novel coronavirus subtype found in the country, has not undergone any major mutation since June and there is no indication that the vaccine or diagnostics strategy would be hindered.
0
shares
ShareTweetSavePostSend
 

💡 One News Page Knowledge: Other News Mentions

Severe acute respiratory syndrome coronavirus 2 Severe acute respiratory syndrome coronavirus 2 Virus strain that causes coronavirus disease 2019 (COVID-19)

Study says 43% of children have antibodies of coronaviruses

A recent study published in Science magazine says it could be that children already have antibodies to other coronaviruses and these antibodies may block..
IndiaTimes
Routine testing for COVID-19 can make surgery safer: Study [Video]

Routine testing for COVID-19 can make surgery safer: Study

Routine testing patients for COVID-19 before major surgery could reduce the risk of respiratory complications and save lives, a new study revealed. Researchers working together around the world found that using a nasal swab test to confirm that asymptomatic patient was not infected with SARS-CoV-2 was associated with a lower rate of postoperative complications. The main benefit was seen before major surgery and areas with a higher rate of COVID-19. Swab testing gave an opportunity for surgeons to identify asymptomatic infected patients and postpone their operation, avoiding the severe risk of COVID-19 complications after surgery. Routine testing also helped to prevent cross-infection from patients with no symptoms to other elective surgical patients upon admission to hospital. The COVIDSurg toolkit will support individual hospitals, regions, and countries during a major global reorganisation of surgical services during the pandemic and beyond.

Credit: ANI    Duration: 01:21Published
Study focuses on new tool that enables easy, effective disease tracking [Video]

Study focuses on new tool that enables easy, effective disease tracking

A new open source, a cloud-based tool called IDseq makes it possible to rapidly detect, identify, and track emerging pathogens such as SARS-CoV-2. This tool can identify pathogens before there is an available complete genome sequence; thus, it can be used for current infectious disease outbreaks and also for emerging ones. This will substantially aid in preventing future pandemics. The study was published in the journalGigaScience. The coronavirus pandemic demonstrates the importance of global infectious disease monitoring. Finding the cause of an infectious disease outbreak is challenging, especially if it stems from a previously unknown pathogen. IDseq, an open-source, cloud-based metagenomic analysis platform, identifies both novel and existing disease-causing pathogens from a given sample - be it a human, animal, or parasite - to provide an actionable report of what is happening on the ground in labs and clinics anywhere in the world. The new user-friendly IDseq software is open source and freely available to the global health community, reducing the barrier of entry to metagenomics.

Credit: ANI    Duration: 01:00Published

Department of Biotechnology

Rs 900 crore allocated for COVID vaccine development: FM Sitharaman [Video]

Rs 900 crore allocated for COVID vaccine development: FM Sitharaman

Addressing a joint press conference in the national capital on November 12, Union Finance Minister Nirmala Sitharaman spoke on COVID Suraksha Mission.She said, "Rs 900 crore provided for COVID Suraksha Mission for research and development of the Indian COVID vaccine to the Department of Biotechnology."

Credit: ANI    Duration: 01:31Published

You Might Like


Related news from verified sources

'Unexplained illness' puts Johnson & Johnson coronavirus vaccine study on pause

A coronavirus vaccine study by Johnson & Johnson has been put on pause after one of the study’s participants had an “unexpected illness.”
Upworthy

A Study In India Shows That Children Play Major Role In Coronavirus Transmission

A massive study of coronavirus cases in India found that a significant number of virus transmissions originate from and happen between children.
NPR Also reported by •NaturalNews.com

Study: Coronavirus Antibodies May Last 3 Months After Initial Infection

Coronavirus antibodies might exist in a person's blood at least three months after they were infected, according to a study in Science Immunology.
Newsmax Also reported by •NaturalNews.comNews24FT.com